![]() |
市場調査レポート
商品コード
1619046
血圧監視装置の市場規模、シェア、成長分析、製品別、最終用途別、地域別 - 産業予測、2024~2031年Blood Pressure Monitoring Devices Market Size, Share, Growth Analysis, By Product, By End Use, By Region - Industry Forecast 2024-2031 |
||||||
|
血圧監視装置の市場規模、シェア、成長分析、製品別、最終用途別、地域別 - 産業予測、2024~2031年 |
出版日: 2024年12月18日
発行: SkyQuest
ページ情報: 英文 260 Pages
納期: 3~5営業日
|
血圧監視装置の世界市場規模は、2022年に17億9,000万米ドルと評価され、2023年の19億9,000万米ドルから2031年には45億4,000万米ドルに成長し、予測期間(2024~2031年)のCAGRは10.9%で成長する見通しです。
世界市場は、ライフスタイルの変化に起因する高血圧有病率の上昇に牽引され、2019年のWHOデータでは約12億8,000万人が罹患しており、大きな成長を遂げています。高齢者人口の増加、血圧モニターに対する需要の高まり、座りがちな行動などの要因が主な要因となっています。血圧モニタリングプログラムを通じて国民の意識を高めることを目的とした政府のイニシアチブは、市場の可能性をさらに高めます。モバイルベースの血圧モニタリングシステムやデジタル血圧計のような先進技術の採用は、ワイヤレスでの患者情報転送やユーザーフレンドリーな操作を提供するウェアラブルデバイスの人気とともに増加傾向にあります。さらに、健康データと投薬スケジュールを追跡するためのmヘルス技術の出現は、自己モニタリング機器の増加傾向と相まって、今後数年間の市場成長をさらに刺激すると予想されます。
Global Blood Pressure Monitoring Devices Market size was valued at USD 1.79 billion in 2022 and is poised to grow from USD 1.99 billion in 2023 to USD 4.54 billion by 2031, growing at a CAGR of 10.9% during the forecast period (2024-2031).
The global market is experiencing significant growth driven by the rising prevalence of hypertension, attributed to changing lifestyles, with approximately 1.28 billion individuals affected as per WHO data from 2019. Factors such as an increasing geriatric population, heightened demand for blood pressure monitors, and sedentary behaviors are key contributors. Government initiatives aimed at public awareness through blood pressure monitoring programs further enhance market potential. The adoption of advanced technology like mobile-based BP monitoring systems and digital sphygmomanometers is on the rise, alongside the popularity of wearable devices that offer wireless patient information transfer and user-friendly operation. Additionally, the emergence of mHealth technology for tracking health data and medication schedules, coupled with the growing trend of self-monitoring devices, is expected to further stimulate market growth in the coming years.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Blood Pressure Monitoring Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Blood Pressure Monitoring Devices Market Segmental Analysis
Global Blood Pressure Monitoring Devices Market is segmented by product, end use and region. Based on product, the market is segmented into sphygmomanometer/aneroid bp monitor, automated/digital blood pressure monitor, ambulatory blood pressure monitor, transducers and instruments and accessories. Based on end use, the market is segmented into hospitals, ambulatory surgical centers & clinics and homecare. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Blood Pressure Monitoring Devices Market
The Global Blood Pressure Monitoring Devices market is significantly driven by the rising prevalence of hypertension, a condition that contributes to high mortality rates worldwide. Various lifestyle changes, including unhealthy diets, reduced physical activity, excessive alcohol consumption, and mental stress, have exacerbated the issue. For instance, data from the CDC indicates that in 2018 alone, there were approximately 494,873 deaths in the U.S. attributed to high blood pressure. Furthermore, as of 2010, it was reported that around one-third of adults globally suffered from hypertension, with only 13.8% managing to keep their blood pressure under control. This alarming trend amplifies the need for reliable and precise blood pressure monitors, thus propelling the growth of the blood pressure monitoring devices market.
Restraints in the Global Blood Pressure Monitoring Devices Market
The global Blood Pressure Monitoring Devices market faces significant restraints, primarily due to the high cost of technologically advanced devices and concerns regarding their accuracy. In many developing nations, the prevalence of BP monitors is limited, largely because their prices are prohibitive, hindering widespread adoption. Additionally, certain automatic and manual monitors lack proper validation, leading to inaccurate measurements that undermine trust in these tools. This skepticism in both healthcare sectors and among the general public further reduces usage rates. A study by the American Heart Association in 2020 indicated that an alarming 93.4% of BP monitors sold online in Australia were found to be non-validated, highlighting the issue.
Market Trends of the Global Blood Pressure Monitoring Devices Market
The Global Blood Pressure Monitoring Devices market is witnessing a significant trend towards home care, driven by a growing preference for more personalized and convenient healthcare solutions. Key players, including Omron Healthcare, are actively introducing innovative blood pressure monitors specifically designed for home use, catering to the rising demand among patients seeking effective self-management tools. Additionally, the integration of Bluetooth technology in these devices enhances patient experience, enabling seamless data transfer to healthcare providers and facilitating comprehensive follow-up care. This shift not only ensures better health outcomes but also aligns with the broader movement towards telehealth and remote patient monitoring, shaping the future of blood pressure management.